The Chemours Company
Case Overview
Status: | Status: Investigating |
Company Name: | Company Name: The Chemours Company |
Case Number: | Case Number: 1:24cv00361 |
Class Period: | Class Period: 02/10/2023 - 02/28/2024 |
Ticker: | Ticker: CC |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Delaware on behalf of those who acquired The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) securities during the period of February 10, 2023 through February 28, 2024, inclusive (“the Class Period”). Investors have until May 20, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
On February 13, 2024, Chemours disclosed that it was postponing the release of its financial results and conference call related to its fourth quarter and full year 2023 results. Chemours stated that it was delaying results because the Company is “evaluating its internal control over financial reporting as of December 31, 2023 with respect to maintaining effective controls related to information and communications,” and because the Company’s Audit Committee “needs additional time to complete a related internal review.” On this news, the price of Chemours shares declined by $3.85 per share, or approximately 12.6%, from $30.49 per share on February 13, 2024 to close at $26.64 on February 14, 2024.
On February 13, 2024, Chemours disclosed that it was postponing the release of its financial results and conference call related to its fourth quarter and full year 2023 results. Chemours stated that it was delaying results because the Company is “evaluating its internal control over financial reporting as of December 31, 2023 with respect to maintaining effective controls related to information and communications,” and because the Company’s Audit Committee “needs additional time to complete a related internal review.” On this news, the price of Chemours shares declined by $3.85 per share, or approximately 12.6%, from $30.49 per share on February 13, 2024 to close at $26.64 on February 14, 2024.